Neurology
A New Pathway to Episodic Migraine Relief
Migraine has been deemed the “forgotten epidemic.” As a common neurological disease, it imposes a significant personal burden on a migraine sufferer’s quality of life. The incidence of migraine has been shown to be the third most prevalent illness worldwide but migraine often remains undertreated. According to the Migraine Research Foundation, more than half of […]
DURATION
1 hr
PROFESSION
Physician
# OF CREDITS
1
ACCREDITATION
Mainpro+
EXPIRY DATE
2023-04-14
Migraine has been deemed the “forgotten epidemic.” As a common neurological disease, it imposes a significant personal burden on a migraine sufferer’s quality of life. The incidence of migraine has been shown to be the third most prevalent illness worldwide but migraine often remains undertreated. According to the Migraine Research Foundation, more than half of all migraine sufferers are undiagnosed.
There is an overwhelming need for treatment of this major health condition. Current treatments can provide relief, but new treatment innovations are now becoming available to provide viable options, including for episodic migraine.
This program is made possible through educational support from AbbVie.
Faculty
Dr. Sian Spacey
Dr. James Kim
Dr. Jeffrey Habert
Dr. Anas Nseir
Learning objectives
- Recognize the burden of migraine and its debilitating effects.
- Differentiate episodic migraine from other primary headache types by identifying phases, symptoms and occurrence.
- Identify current treatment options for episodic migraine and evaluate new innovative treatment options for acute or preventive treatment.
- Counsel patients about managing episodic migraine with appropriate treatment and patient resources.
Accreditation
This Self-Learning program has been certified by the College of Family Physicians of Canada for up to 1.0 Mainpro+ Credit(s).
Cert+ Program ID#: 196993